A prophylactic protocol was initiated, whereby two cycles of either PBS, the STING-LNPs, CpG-ODNs, or the combination therapy was administered intravenously on days 0 and 4 followed by tumor inoculation on day 14. The gene discussed is STING1; the disease is neoplasm.